Guatemala vs Madagascar: HIV-positive TB patients on ART (antiretroviral therapy)
Guatemala
81.0%
in 2024
Madagascar
81.0%
in 2024
Guatemala rank
112th
Madagascar rank
112th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Guatemala
- Madagascar
How they compare
Guatemala currently reports 81.0% against 81.0% in Madagascar, a difference of 0.0%.
The two have swapped places 3 times across 15 shared years of data; in 2009 it was Guatemala ahead.
Guatemala ranks 112th and Madagascar ranks 112th of 144 countries.
Guatemala has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guatemala | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 71.0% | 29.0% | Guatemala |
| 2010s | 85.9% | 77.2% | 8.7% | Guatemala |
| 2020s | 88.6% | 69.2% | 19.4% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Guatemala or Madagascar?
- Guatemala, at 81.0% against 81.0% in Madagascar as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Guatemala and Madagascar?
- 0.0%, with Guatemala ahead.
- How many years of comparable data are there for Guatemala and Madagascar?
- 15 years are reported by both, from 2009 to 2024.
- How do Guatemala and Madagascar rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Guatemala ranks 112th and Madagascar ranks 112th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.